Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Carvedilol NDC 55154-5676 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

d3af12b4 8e76 2323 e053 2a95a90ac0e5 00

d3af12b4 8e76 2323 e053 2a95a90ac0e5 00

Carvedilol tablets, USP is a medication used to treat heart failure and high blood pressure. Each film-coated tablet contains 25mg of Carvedilol, USP. The tablets are round, white, and have "M" on one side and "C34" on the other. They are available in a blister pack of 10 tablets. The usual dosage should be followed by reading the product insert, patient information leaflet, prescribing information, precautions, and warnings. The tablets must be stored at 20° to 25° C (68° to 77° F), protected from light and moisture. The product contains warnings about keeping it out of reach of children as the unit dose package is not child resistant. The drug is manufactured by Mylan Pharmaceuticals Inc. and distributed by Cardinal Health in Ohio. The package is intended for institutional use only.*

d3af12b4 8e76 2323 e053 2a95a90ac0e5 01

d3af12b4 8e76 2323 e053 2a95a90ac0e5 01

The text is a description of a medication package of Carvedilol tablets, USP with dosage and storage information. The tablets come in a yellow blister with ten tablets in each package, each of which contains 12.5 mg Carvedilol USP. The tablets are white and round with "M" on one side and "C33" on the other. The information instructs users to read the product insert and patient information leaflet for precautions and warnings. The tablets should be stored at 20° to 25° C, protected from light and moisture. The package also includes a warning that it is not child-resistant and is intended only for institutional use. The package is manufactured in India by Mylan Pharmaceuticals Inc. and distributed in the US by Mylan Institutional Inc. through Cardinal Health.*

d3af12b4 8e76 2323 e053 2a95a90ac0e5 02

d3af12b4 8e76 2323 e053 2a95a90ac0e5 02

This is a package of Carvedilol tablets, a medication used for treating heart failure and high blood pressure. Each film-coated tablet contains 6.25 mg of Carvedilol, USP. The tablets are round, white, unscored, debossed with "M" on one side and "C32" on the other side, and appear yellow in amber blister. The product insert and patient information leaflet should be consulted for dosage, precautions, and warnings. The tablets should be stored at a controlled room temperature (20°C to 25°C) and protected from light and moisture. This package is not child-resistant and is intended for institutional use only. The medication is manufactured in India by Mylan Pharmaceuticals and distributed in the USA by Mylan Institutional Inc. and Cardinal Health.*

d3af12b4 8e76 2323 e053 2a95a90ac0e5 03

d3af12b4 8e76 2323 e053 2a95a90ac0e5 03

Carvedilol Tablets USP, with NDC 55154-5677-0 and RXONLY warning, are available in 3.125mg strength with 10 tablets in a blister pack. The tablets are blue, round, un-scored, and film-coated, with *C31 debossed on one side and *G58 on the other side. It is advised to refer to the Patient Information Leaflet for the proper dosage, precautions, and warnings. The package should be stored at room temperature between 20 to 25°C, away from light and moisture. This package is not intended for child use and should be kept away from the reach of children. This drug is made in India and distributed by Mylan Institutional Inc., a part of Cardinal Health in the USA.*

Figure 1. Survival Analysis for Copernicus (Intent-to-treat) - image 05

Figure 1. Survival Analysis for Copernicus (Intent-to-treat) - image 05

Figure 2. Effect on Mortality for Subgroups in Copernicus - image 06

Figure 2. Effect on Mortality for Subgroups in Copernicus - image 06

Figure 3. Survival Analysis for Capricorn (Intent-to-treat) - image 07

Figure 3. Survival Analysis for Capricorn (Intent-to-treat) - image 07

Figure 4. Effects on Mortality for Subgroups in Capricorn - image 08

Figure 4. Effects on Mortality for Subgroups in Capricorn - image 08

Carvedilol Structural Formula - image 09

Carvedilol Structural Formula - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.